$1.99
▲ $0.08 (+3.9%)
KPTI
Karyopharm Therapeutics Inc. Common Stock
Health Care
Investor Score
40D
Weak rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
6
Technical
38
Fundamental
48
Growth
38
Fair Value
100
News
58
Quality
42
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.